Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. - Wikidata - wikimedia - TriplyDB

Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

http://www.wikidata.org/entity/Q34699180

about

Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.Pilot study of a multi-pronged intervention using social norms and priming to improve adherence to antiretroviral therapy and retention in care among adults living with HIV in Tanzania.Antiretroviral therapy for refugees and internally displaced persons: a call for equity Hookworm infection is associated with decreased CD4+ T cell counts in HIV-infected adult Ugandans.Correlates of non-adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam.Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy.Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana Adherence to antiretroviral treatment and correlation with risk of hospitalization among commercially insured HIV patients in the United States Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings.Household food insecurity associated with antiretroviral therapy adherence among HIV-infected patients in Windhoek, Namibia Development of an electronic medical record based alert for risk of HIV treatment failure in a low-resource setting.Medication possession ratio associated with short-term virologic response in individuals initiating antiretroviral therapy in Namibia.Medication possession ratio predicts antiretroviral regimens persistence in Peru.Chemokine (C-C motif) receptor 5 -2459 genotype in patients receiving highly active antiretroviral therapy: race-specific influence on virologic success Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.Cognitive functioning, depression, and HIV medication adherence in India: a randomized pilot trial.Medication possession ratio: predicting and decreasing loss to follow-up in antiretroviral treatment programs in Côte d'Ivoire Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life Comparison of pharmacy-based measures of adherence to antiretroviral therapy as predictors of virological failure Effects of eHealth interventions on medication adherence: a systematic review of the literature.Rationale and design of a randomized study of short-term food and cash assistance to improve adherence to antiretroviral therapy among food insecure HIV-infected adults in Tanzania.Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.Medication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis.Improved antiretroviral refill adherence in HIV-focused community pharmacies.A proposal for quality standards for measuring medication adherence in research Warfarin therapy in the HIV medical home model: low rates of therapeutic anticoagulation despite adherence and differences in dosing based on specific antiretrovirals.Current use of statins reduces risk of HIV rebound on suppressive HAART Pharmacy refill data can be used to predict virologic failure for patients on antiretroviral therapy in Brazil.Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia.Focus on increasing treatment self-efficacy to improve human immunodeficiency virus treatment adherence.Cost of behavioral interventions utilizing electronic drug monitoring for antiretroviral therapy adherence Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India Association between daily antiretroviral pill burden and treatment adherence, hospitalisation risk, and other healthcare utilisation and costs in a US medicaid population with HIV Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol.Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawi's Option B+ Program Short communication: Late refills during the first year of antiretroviral therapy predict mortality and program failure among HIV-infected adults in urban Zambia.Food insecurity is associated with increased risk of non-adherence to antiretroviral therapy among HIV-infected adults in the Democratic Republic of Congo: a cross-sectional study.Measuring Health Literacy Among Adults with HIV Infection in Mozambique: Development and Validation of the HIV Literacy Test

P2860

Q26783160-95841DC9-8A9F-443E-8CA4-55FD371DB045 Q30558310-F6417F91-B26E-4A26-B236-7410F128B90E Q33653200-6687ADFE-8ADC-49F6-9092-6D4F998EBEB6 Q33733850-761E37CC-A627-4EE7-8479-A43BED6860E1 Q33773331-B211676E-642E-49AF-B4A9-FF305F675B7F Q33774290-82CC0BE7-3BA3-4777-855F-50E24230DCD2 Q33869982-2549685F-2E44-47A8-BDDC-1838CC1DE640 Q33941267-D42543BF-8A98-4786-95EB-51CE76673FD2 Q34181784-D87E0BCC-A665-4BBA-ABEF-E0C0A72AFD52 Q34325958-2766EC94-7BAD-499C-A1A5-E0162CE3CC7D Q34430645-48D2CF1C-8BE3-4BB6-82F0-44200B442174 Q34497703-A168546B-5035-4C2B-A371-47A2754CA0A3 Q34627263-ABDD0006-259B-4817-AD91-A2E5F8EB9953 Q35009374-4FDA85E6-620D-476F-BD5F-0E488647AAC5 Q35043700-2D7EE992-AA50-418C-94BD-19451076F2AC Q35102225-CF31E5D7-F125-4977-95E9-1304D146462F Q35136380-D9A2D372-AB5E-45CA-8246-242F8201E0C3 Q35190245-EE3CBB4D-3DA5-4BFC-86BE-A2C7AA56E4A9 Q35238134-849DBCDC-45C5-4E24-906C-B28EEAED2D74 Q35370804-58779134-5444-4F9F-BC9E-A84626277452 Q35752693-286FBD45-2828-46FE-8110-7D2B1396C8A6 Q35828392-DDD50392-2465-4BA2-8552-C41022385720 Q35917573-AFD8169A-3F60-4CB7-A4D8-42A3D99382DC Q35917583-730F033C-662B-424D-9935-94A946C6B88D Q35955792-19A5AA94-F50A-45CD-8A64-7A9848F6AF0F Q36166079-05AAD02F-4E6C-4DAE-8237-EE49183C6DBB Q36210156-D8578007-197D-417E-80B1-C8463CEA33EC Q36291878-9C283E1D-EA23-4493-8F9C-5835B1647E1D Q36294013-3A03D4EF-8B4E-4F33-B5C3-C28212F9C59F Q36399318-35B280F6-DD40-4280-B483-97C87C94E047 Q36506174-B986250A-0A2F-4129-864D-3EB852C30B78 Q36671079-67D1D3F7-9102-4028-974E-72752A0A5E4E Q36848372-CED558B7-E283-4121-99AB-92E6B308D9F5 Q36906379-27CF0B14-53E0-45D4-89C2-07DC6D92AD43 Q37069682-D216F1E2-36AE-4658-82EC-23716B00CBBA Q37275804-7E02E53C-3253-4A9F-870F-F4D056B0500A Q37339299-A973B85F-1AE2-439F-921B-8953A9198F05 Q37460044-B04B15F4-11B7-422C-AE67-059B8FCA5111 Q37483968-E37365E3-F2B1-4242-B556-A3DC185CF198 Q37639495-6A7B14F3-9D76-4CFC-B2D5-39CB4AEA945E

P2860

Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

http://www.wikidata.org/entity/Q34699180

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Pharmacy adherence measures to ...... ions for treatment monitoring.

@ast

Pharmacy adherence measures to ...... ions for treatment monitoring.

@en

Pharmacy adherence measures to ...... ions for treatment monitoring.

@nl

type

label

Pharmacy adherence measures to ...... ions for treatment monitoring.

@ast

Pharmacy adherence measures to ...... ions for treatment monitoring.

@en

Pharmacy adherence measures to ...... ions for treatment monitoring.

@nl

prefLabel

Pharmacy adherence measures to ...... ions for treatment monitoring.

@ast

Pharmacy adherence measures to ...... ions for treatment monitoring.

@en

Pharmacy adherence measures to ...... ions for treatment monitoring.

@nl

P1433

Q34699180-3CB5549F-87D8-4BF7-ADB1-ED152DE71C24

P1476

Q34699180-09D17AB1-F8D4-4C63-82C0-6CF7CED65EB6

P2093

Q34699180-247ED211-D9DA-4607-A558-68974387F425

Q34699180-5AA3298B-4E81-4E74-A0E1-B986769B61A1

Q34699180-97C5A34C-2B7D-48E2-B2C8-3B92A4746524

Q34699180-ABFF808D-5BF6-4E33-95B1-EAD30B1EC1E8

Q34699180-C35AD622-DE3E-4392-A86C-A3AAF32F5E25

Q34699180-E2FE8510-6749-43BA-9F36-C3AF5713EAFA

P2860

Q34699180-09E5D346-ECA3-434C-9862-C0156CF1A409

Q34699180-12412CD3-90D7-4CA5-B13F-F19DE64BB0FF

Q34699180-18294701-1993-4BF3-97AA-4D270FB453EB

Q34699180-19E9441B-6DAF-410F-B4C1-5236F9EC1365

Q34699180-1C23369E-2A8F-4B5C-B680-D0C856007DBF

Q34699180-1F78C797-10AF-43CE-838A-FDC10033D7E9

Q34699180-25F6E67F-4E76-47F1-B023-0BCF3D6AD386

Q34699180-289C0E19-1965-4684-8116-5CE31EE03EF6

Q34699180-43A3DBB9-C774-4B11-84DD-468D049C65B9

Q34699180-4EA2F580-FAFE-441E-A34C-C72D72A3F5CE

P304

Q34699180-79C185BC-67A6-411D-A32B-67C6F9C91614

P31

Q34699180-DEF815A0-3665-45D7-BE04-D03CEB13705C

P356

Q34699180-B2060B91-FB0A-4254-892F-739566B5F48A

P407

Q34699180-D8EC2FA1-103A-4B85-B815-388D2843D98F

P433

Q34699180-BA5F9A7B-F20A-4DA3-A380-972DD1E97C67

P478

Q34699180-9B71D549-DDE0-43DC-B71D-98DDD37E6E8D

P50

Q34699180-09C02C1B-E226-4AD4-8C73-672955C10C71

Q34699180-EA163FEE-F23F-455E-8EE5-8E4084C232CA

P577

Q34699180-6A0448DA-BED7-4AC9-B48F-7C9A7481968F

P5875

Q34699180-91EFB80F-55FA-4AC7-A898-596D875D138D

P698

Q34699180-9DEAB523-D0A6-4700-9C3C-A559AE5662D7

P921

Q34699180-D4C86372-D1FF-4F44-9040-C54DAE18F1B8

P932

Q34699180-7CFFC62C-618A-45C0-8C7B-23BBECE2CA59

P356

P1433

Clinical Infectious Diseases

P1476

Pharmacy adherence measures to ...... ions for treatment monitoring.

@en

P2093

Christine A Wanke

http://www.w3.org/2001/XMLSchema#string

Julian H Elliott

http://www.w3.org/2001/XMLSchema#string

Karen Kelley

http://www.w3.org/2001/XMLSchema#string

Michael R Jordan

http://www.w3.org/2001/XMLSchema#string

Silvia Bertagnolio

http://www.w3.org/2001/XMLSchema#string

Steven Y Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy

Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.

Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators.

Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center.

Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.

Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users

Assessing the utility of a community pharmacy refill record as a measure of adherence and viral load response in patients infected with human immunodeficiency virus.

P304

493-506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIQ167

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Sharon R. Lewin

James H McMahon

P577

2011-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49765138

http://www.w3.org/2001/XMLSchema#string

P698

21245156

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3060901

http://www.w3.org/2001/XMLSchema#string